New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
10:26 EDTASPXAuspex Systems opens for trade at $15.00, IPO priced at $12.00
Auspex Systems (ASPX) priced 7M shares at $12.00. Stifel and BMO Capital acted as joint book running managers for the offering.
News For ASPX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
16:27 EDTASPXOn The Fly: Closing Wrap
Subscribe for More Information
12:57 EDTASPXOn The Fly: Midday Wrap
Subscribe for More Information
09:22 EDTASPXOn The Fly: Pre-market Movers
HIGHER: Auspex Pharmaceuticals (ASPX), up 83.1% after Phase 3 trial of SD-809 met primary efficacy endpoint... Volcano (VOLC), up 55.3% after Philips (PHG) announced it will acquire the company for $18.00 per share... Paramount Gold and Silver (PZG), up 35.9% after announcing a merger agreement with Coeur Mining... Cerus (CERS), up 17.8% after FDA approves Intercept Blood System... American Apparel (APP), up 15.5% after terminating Dov Charney for cause... TASER (TASR), up 6.1% after LAPD purchases 860 AXON body-worn video cameras... Idera Pharmaceuticals (IDRA), up 5.9% after being called a top 2015 small cap pick at Piper Jaffray... Kandi Technologies (KNDI), up 7.5% after selling 1,000 electric vehicles to Chengdu City... Stillwater Mining (SWC), up 2.7% after being upgraded to Buy from Neutral at Goldman. DOWN AFTER EARNINGS: FedEx (FDX), down 3.5%... Joy Global (JOY), down 1.7%. ALSO LOWER: POZEN (POZN), down 13.1% after receiving a second complete response letter from the FDA for Yosprala... Cliffs Natural (CLF), down 13.1% after price target cut to $1 from $10 at Credit Suisse... Coeur Mining (CDE), down 2.8% following merger agreement with Paramount Gold and Silver.
07:49 EDTASPXAuspex Pharmaceuticals price target raised to $70 from $42 at William Blair
Subscribe for More Information
07:48 EDTASPXAuspex Pharmaceuticals price target raised to $61 from $40 at Stifel
Subscribe for More Information
December 16, 2014
18:19 EDTASPXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Dave & Buster's (PLAY), up 7.3%... Darden Restaurants (DRI), up 1.6%. ALSO HIGHER: Auspex Pharmaceuticals (ASPX), up 66.5% after Phase 3 trial of SD-809 met primary efficacy endpoint... Cerus (CERS), up 26.6% after FDA approves Intercept Blood System... American Apparel (APP), up 8.6% after terminating Dov Charney for cause. DOWN AFTER EARNINGS: Heico (HEI), down 1%. ALSO LOWER: Cliffs Natural (CLF), down 10% after price target cut to $1 from $10 at Credit Suisse... Linn Energy (LINE), down 3% after being downgraded to Neutral from Outperform at RW Baird.
16:11 EDTASPXAuspex reports Phase 3 trial of SD-809 met primary efficacy endpoint
Subscribe for More Information
16:09 EDTASPXAuspex says Phase 3 trial of SD-809 met primary efficacy endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use